Cargando…
Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800838/ https://www.ncbi.nlm.nih.gov/pubmed/35094260 http://dx.doi.org/10.1007/s12149-021-01712-6 |
| _version_ | 1784642313817948160 |
|---|---|
| author | Thaweerat, Wajana |
| author_facet | Thaweerat, Wajana |
| author_sort | Thaweerat, Wajana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8800838 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88008382022-01-31 Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy Thaweerat, Wajana Ann Nucl Med Letter to the Editor Springer Singapore 2022-01-30 2022 /pmc/articles/PMC8800838/ /pubmed/35094260 http://dx.doi.org/10.1007/s12149-021-01712-6 Text en © The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Thaweerat, Wajana Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy |
| title | Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy |
| title_full | Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy |
| title_fullStr | Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy |
| title_full_unstemmed | Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy |
| title_short | Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy |
| title_sort | optimization of fdg pet study after mrna covid-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800838/ https://www.ncbi.nlm.nih.gov/pubmed/35094260 http://dx.doi.org/10.1007/s12149-021-01712-6 |
| work_keys_str_mv | AT thaweeratwajana optimizationoffdgpetstudyaftermrnacovid19vaccinationtoreducetheinterferenceofvaccineassociatedhypermetaboliclymphadenopathy |